APOA1 and metabolic dysfunction-associated steatotic liver disease: In model 3, which adjusted for model 2 and HDL and LDL, the relationship between ApoA1 and baPWV in male NAFLD patients remained significant (coefficient, 156.42; 95% CI [49.34–263.50], P < 0.05).